ES2156765A1 - Composicion de un producto aplicable a la piel. - Google Patents

Composicion de un producto aplicable a la piel.

Info

Publication number
ES2156765A1
ES2156765A1 ES009902435A ES9902435A ES2156765A1 ES 2156765 A1 ES2156765 A1 ES 2156765A1 ES 009902435 A ES009902435 A ES 009902435A ES 9902435 A ES9902435 A ES 9902435A ES 2156765 A1 ES2156765 A1 ES 2156765A1
Authority
ES
Spain
Prior art keywords
urea
dipropionate
excipient
blend
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES009902435A
Other languages
English (en)
Other versions
ES2156765B1 (es
Inventor
Herrando Carlos Postigo
Foz Cosme Micolau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to ES9902435A priority Critical patent/ES2156765B1/es
Publication of ES2156765A1 publication Critical patent/ES2156765A1/es
Application granted granted Critical
Publication of ES2156765B1 publication Critical patent/ES2156765B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Composición de un producto aplicable a la piel. En la obtención de un kilogramo de dicho producto se utiliza: ácido retinoicode 0,5 a 2 gramos. Betametasona dipropianato de 0,5 a 6 gramos. Urea de 100 a 200 gramos. Excipiente de 792 a 899 gramos. La composición se aplica: a la piel, incluyendo el cuero cabelludo y en cosmética.
ES9902435A 1999-11-05 1999-11-05 Composicion de un producto aplicable a la piel. Expired - Fee Related ES2156765B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9902435A ES2156765B1 (es) 1999-11-05 1999-11-05 Composicion de un producto aplicable a la piel.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9902435A ES2156765B1 (es) 1999-11-05 1999-11-05 Composicion de un producto aplicable a la piel.

Publications (2)

Publication Number Publication Date
ES2156765A1 true ES2156765A1 (es) 2001-07-01
ES2156765B1 ES2156765B1 (es) 2002-02-01

Family

ID=8310494

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9902435A Expired - Fee Related ES2156765B1 (es) 1999-11-05 1999-11-05 Composicion de un producto aplicable a la piel.

Country Status (1)

Country Link
ES (1) ES2156765B1 (es)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4294852A (en) * 1973-11-01 1981-10-13 Johnson & Johnson Skin treating compositions
ES8706027A1 (es) * 1986-03-24 1987-05-16 Belda Galiana Manuel F Procedimiento de obtencion de una composicion para el tratamiento de vitiligo
EP0293503A1 (en) * 1987-06-03 1988-12-07 Key Pharmaceuticals, Inc. Urea stabilized with a lactone in various pharmaceutical and cosmetic preparations
ES2047456A1 (es) * 1992-07-31 1994-02-16 Postigo Herrando "composicion para la obtencion de un producto cosmetico y similar"
WO1996001633A1 (es) * 1994-07-07 1996-01-25 Lujambio Galdeano Ignacio Anto Nueva formulacion para el tratamiento topico de la psoriasis
ES2083333A1 (es) * 1994-09-22 1996-04-01 Corral Begona Gozalo Crema para el tratamiento de la psoriasis.

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4294852A (en) * 1973-11-01 1981-10-13 Johnson & Johnson Skin treating compositions
ES8706027A1 (es) * 1986-03-24 1987-05-16 Belda Galiana Manuel F Procedimiento de obtencion de una composicion para el tratamiento de vitiligo
EP0293503A1 (en) * 1987-06-03 1988-12-07 Key Pharmaceuticals, Inc. Urea stabilized with a lactone in various pharmaceutical and cosmetic preparations
ES2047456A1 (es) * 1992-07-31 1994-02-16 Postigo Herrando "composicion para la obtencion de un producto cosmetico y similar"
WO1996001633A1 (es) * 1994-07-07 1996-01-25 Lujambio Galdeano Ignacio Anto Nueva formulacion para el tratamiento topico de la psoriasis
ES2083333A1 (es) * 1994-09-22 1996-04-01 Corral Begona Gozalo Crema para el tratamiento de la psoriasis.

Also Published As

Publication number Publication date
ES2156765B1 (es) 2002-02-01

Similar Documents

Publication Publication Date Title
GB2288732B (en) Pharmaceutical compositions
GB9918030D0 (en) Skin care composition
BG104056A (en) Triazole compounds and their use as dopamine-d3-ligands
HK1034189A1 (en) An acidified composition for topical treatment of nail and skin conditions.
CA2135575A1 (fr) Composition cosmetique contenant en tant qu'agent reducteur un n-mercapto-alkyl alcanediamide ou l'un de ses sels cosmetiquement acceptable
EP0641204A4 (en) 17-ETHERS AND THIOETHERS OF 4-AZA-STEROIDES.
WO2001066564A3 (en) Gamma-secretase inhibitors
HUP0000558A3 (en) Use of active d vitamin analogues for producing pharmaceutical composition for the treatment of prostatic diseases
CA2245142A1 (en) New phenanthridines
CA2417630A1 (en) Novel compositions of minoxidil
WO1996012498A3 (en) Dermatological compositions containing benzoyl peroxide and a compound reducing skin irritation
UA56989C2 (uk) ФІЗІОЛОГІЧНО АКТИВНИЙ ПЕГ-КОН'ЮГАТ <font face="Symbol">a</font>-ІНТЕРФЕРОНУ, СПОСІБ ЙОГО ОДЕРЖАННЯ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ НА ЙОГО ОСНОВІ ТА СПОСІБ ЛІКУВАННЯ АБО ПРОФІЛАКТИКИ ІМУНОМОДУЛЯТОРНИХ ЗАХВОРЮВАНЬ
MX9708800A (es) Compuestos biciclicos aromaticos.
AU2001240940A1 (en) Cosmetic and dermatological composition for psoriatic skin, scalp treatment and care
MX9805705A (es) Compuestos biaromaticos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
WO1998009599A3 (fr) Utilisation d'un nouvel acide bicafeoylquinique dans le traitement de l'hepatite b et des maladies liees a des retrovirus, et derives de cet acide bicafeolyquinique
TR200002248T2 (tr) Yeni dihidroksiheksanoik asit türevleri
DK0700898T3 (da) L-carnitinsalt og kosmetiske og farmaceutiske præparater indeholdende samme, til behandling af dermatoser.
EP0612513A3 (en) External skin treatment composition.
MX9708803A (es) Compuestos biaromaticos de propinilo o dienilo.
ITRM930291A0 (it) Procedimento per la preparazione di biopolimeri iodurati con attivita'disinfettante e cicatrizzante, e biopolimeri iodurati cosi' ottenuti.
IL126235A (en) Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use
ES2137125A1 (es) La utilizacion de la sal de zinc del acido glicirretico en preparados contra el acne y las composiciones que contienen dicha sal.
MX9701996A (es) Utlizacion de 3-oxo de 2, 4-diamino-pirimidina o una de sus sales en el tratamiento de desordenes dela maduracion y de la estructuracion del colageno.
BG101126A (en) The use of muramylpeptide compounds

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20010701

Kind code of ref document: A1

Effective date: 20010701

FD2A Announcement of lapse in spain

Effective date: 20180807